Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection?

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.amjsurg.2006.09.013 Byline: M.G. Hurtuk (a), S. Devata (a), K.M. Brown (a), K. Oshima (b), G.V. Aranha (a), J. Pickleman (a), M. Shoup (a) Keywords: Duodenal adenocarcinoma; Duodenum; Pancreas-sparing duodenectomy; Pancreaticoduodenectomy; Periampullary malignancy Abstract: Long-term survival for duodenal adenocarcinoma is inconsistent in the literature, and the biology of duodenal adenocarcinoma is poorly understood. Author Affiliation: (a) Division of Surgical Oncology, Department of Surgery, Loyola University Medical Center, 2160 S. First Ave., Maywood, IL 60153, USA (b) Department of Pathology, Loyola University Medical Center, 2160 S. First Ave., Maywood, IL, USA Article History: Received 12 August 2006; Revised 20 September 2006